Ba and colleagues have reported that the serum expression of Golgi protein-73 (GP73) was higher in HCC patients compared with healthy individuals and serves as a novel biomarker for HCC diagnosis [30]. The gene discussed is GOLM1; the disease is hepatocellular carcinoma.